Health systems today are challenged by the skyrocketing cost of specialty drugs and increasing 340B and reimbursement challenges, all while trying to innovate operating models to enhance care and drive financial performance. Providers are impacted in multiple areas including employee health plan expenses, infusion center alignment and increased regulatory and technology demands.
Many in the industry are addressing these problems head on by doing things differently and investing in new business models. They're aligning pharmacy strategies to population health initiatives, expanding their pharmaceutical footprint in the specialty, retail and ambulatory space, redesigning employee health plans, developing site of care strategies and investing in system-owned specialty pharmacies and joint ventures, and developing shared services models.
The most successful strategies involve creating models of excellence in each of these areas, supported by a careful integration of the strategies to align all these programs.
The Pharmacy Roundtable: Prescription for Innovation will convene pharmacy leaders from across the country to discuss the emerging trends and key drivers impacting pharmacies today. You'll gain insights from your peers who are addressing similar challenges in their organizations, hear from leading experts on strategies for success and leave with actionable takeaways to leverage at your organization.
The Pharmacy Roundtable is eligible for 12.5 credit hours for pharmacists. The Studer Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Who Should Attend
- Executives with responsibility for Pharmacy Services
- Pharmacy Leadership
- Pharmacy Specialists, including:
- Infusion Services
- Retail & Ambulatory Care Pharmacy
- Clinical Services
- 340B Program
- Specialty Pharmacy